Exhibit 107
Calculation of Filing Fee Table
FORM F-1
(Form Type)
Evaxion Biotech A/S
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered Securities
| | | Security Type | | Security Class Title | | Fee Calculation Rate | | Amount Registered | | Proposed Maximum Offering Price Per Unit | | Maximum Aggregate Offering Price | | Fee Rate | | Amount of Registration Fee |
| Fees to be paid | | Equity | | Ordinary Shares DKK 1 nominal value (1) | | 457(c) | | 19,453,796 | | 0.397 | | $ | 7,723,157.00 | | 0.0001476 | | $ | 1,140.00 |
| | | | | | | | | | | | | | | | | | | |
| | | | | Total Offering Amount | | | | | | $ | 7,723,157.00 | | | | $ | 1,140.00 |
| | | | | Total Fees Previously Paid | | | | | | | - | | | | | - |
| | | | | Total Fee Offsets | | | | | | | | | | | | — |
| | | | | Net Fee Due | | | | | | | | | | | $ | 1,140.00 |
| | (1) | The ordinary shares registered hereby will be represented by American Depositary Shares (“ADSs”), each of which will represent ten ordinary shares of the registrant. Such ADSs issuable on deposit of the ordinary shares registered hereby have been registered under a separate registration statement on Form F-6 (File No.: 333-252038). |
| | (2) | Estimated pursuant to Rule 457(c) under the Securities Act, solely for the purposes of calculating the registration fee and based on the average of the high and low prices of the Registrant’s ADSs as reported on The Nasdaq Capital Market on May 2, 2024, which date is within five business days prior to the filing of this Registration Statement, each of which represents ten ordinary shares of the Registrant. |
